Clinical Sexology
Կլինիկական սեքսոլոգիայի ձեռնարկ
Ընդհանուր μժշկության ֆակուլտետի
օտարերկրացի ուսանողների համար
Կլինիկական Սեքսոլոգիա
Դասագրքում հանգամանորեն ներկայացված են սեքսոլոգիայի ժամանակակից
ձեռքμերումները, սեռական զարգացման մարմնասեռական և հոգեսեռական ասպեկտները,
սեքսուալության դրսևորումները, սեռական խանգարումները և աններդաշնակությունները,
սեռական օրգանների μորμոքային հիվանդություններով պայմանավորված սեռական
խանգարումները:
Psychosocial interventions for premature ejaculation
Tamara Melnik1, Stanley Althof2, Álvaro N Atallah3, Maria Eduarda dos Santos Puga4, Sidney Glina5, Rachel Riera6
1Brazilian Cochrane Center, Federal University of Sao Paulo, São Paulo, Brazil. 2Center for Marital and Sexual Health of South
Florida,West Palm Beach, Florida, USA. 3Brazilian Cochrane Centre, Universidade Federal de São Paulo / Escola Paulista deMedicina,
São Paulo, Brazil. 4Brazilian Cochrane Centre, São Paulo, Brazil. 5Instituto H. Ellis, São Paulo, Brazil. 6Brazilian Cochrane Centre,
Universidade Federal de São Paulo, São Paulo, Brazil
Contact address: Tamara Melnik, Brazilian Cochrane Center, Federal University of Sao Paulo, R. Pedro de Toledo, 598, São Paulo,
Brazil. Այս էլ. փոստի հասցեն պաշտպանված է սպամ-բոթերից: Այն տեսնելու համար անհրաժեշտ է միացնել JavaScript.
Editorial group: Cochrane Prostatic Diseases and Urologic Cancers Group.
Publication status and date: New, published in Issue 8, 2011.
Review content assessed as up-to-date: 6 January 2011.
Authors’ conclusions
Overall, there is weak and inconsistent evidence regarding the effectiveness of psychological interventions for the treatment of premature
ejaculation. Three of the four included randomised controlled studies of psychotherapy for PE reported our primary outcome
(Improvement in IELT), and the majority have a small sample size. The early success reports (97.8%) of Masters and Johnson could
not be replicated. One study found a significant improvement from baseline in the duration of intercourse, sexual satisfaction and
sexual function with a new functional-sexological treatment and behavior therapy compared to waiting list. One study showed that the
combination of chlorpromazine and BT was superior to chlorpromazine alone. Randomised trials with larger group samples are still
needed to further confirm or deny the current available evidence for psychological interventions for treating PE.
Peripheral neuropathy: an underdiagnosed cause of erectile dysfunction
Consuelo Valles-Antuña, Jesus Fernandez-Gomez*
and Fernando Fernandez-Gonzalez
Departments of Neurophysiology and *Urology, Hospital Universitario Central de Asturias, Oviedo, Spain
Accepted for publication 26 November 2010
OBJECTIVES
• To assess the prevalence of peripheral
neuropathy in patients with erectile
dysfunction (ED).
• To evaluate the reliability of clinical tests
such as the five-item version of the
International Index of Erectile Function
(IIEF-5) and the Neuropathy Symptom
Score (NSS) classification system in
predicting the concurrence of peripheral
neuropathy.
PATIENTS AND METHODS
• We studied 90 patients who were
consecutively recruited from the
Department of Andrology of the Central
Hospital of Asturias.
• Anamnesis included questions about risk
factors related to ED.
• The severity of ED was classified according
to IIEF-5 scores and symptoms of peripheral
neuropathy were assessed using the NSS.
A brain symphony': First MRI scan video of female orgasm shows how activity lights up EVERY region of the brain
Little is understood about what actually happens to our brains during orgasm - but a video taken an MRI scanner shows for the first time how many regions of the brain are affected.
Scientists say that rather than a few, isolated areas of the brain being affected, the orgasm affects more than 80 brain regions.
The scan was taken of Nan Wise, a 54-year-old sex therapist, who volunteered to sit in an MRI scanner while stimulating herself.
Men’s experience of erectile dysfunction after treatment for colorectal cancer: qualitative interview study
OPEN ACCESS
George Dowswell research fellow 1, Tariq Ismail consultant surgeon 2, Sheila Greenfield senior
lecturer 1, Sue Clifford trial manager 1, Beverley Hancock research fellow 1, Sue Wilson professor of
clinical epidemiology 1
1Cancer and Chronic Disease Team, Primary Care Clinical Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; 2University
Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Birmingham, UK
Abstract
Objectives To examine the experiences of men after treatment for
colorectal cancer, identify barriers to accessing services, and suggest
improvements to providing information in primary and secondary care.
Design Semistructured, qualitative interview study with purposive
sampling and thematic analysis.
Participants 28 patients treated for colorectal cancer...
Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
LIFETIME RISK OF PROSTATE CANcer
in the United States is currently
estimated to be 16%.1 Although
most cases are found at
an early, curable stage, treatment is
costly and urinary, sexual, and bowelrelated
adverse effects are common.2
Even men who choose active surveillance
as an initial management strategy
face anxiety, uncertain prognosis,
and a measurable risk of sepsis with follow-
up biopsies,3 and more than onethird
of those who initially defer therapy
are ultimately treated.4,5 With such a...
